284 related articles for article (PubMed ID: 34452370)
1. Modified-Live Feline Calicivirus Vaccination Reduces Viral RNA Loads, Duration of RNAemia, and the Severity of Clinical Signs after Heterologous Feline Calicivirus Challenge.
Spiri AM; Riond B; Stirn M; Novacco M; Meli ML; Boretti FS; Herbert I; Hosie MJ; Hofmann-Lehmann R
Viruses; 2021 Jul; 13(8):. PubMed ID: 34452370
[TBL] [Abstract][Full Text] [Related]
2. Modified-Live Feline Calicivirus Vaccination Elicits Cellular Immunity against a Current Feline Calicivirus Field Strain in an Experimental Feline Challenge Study.
Spiri AM; Novacco M; Meli ML; Stirn M; Riond B; Fogle JE; Boretti FS; Herbert I; Hosie MJ; Hofmann-Lehmann R
Viruses; 2021 Aug; 13(9):. PubMed ID: 34578316
[TBL] [Abstract][Full Text] [Related]
3. Characterization of an avirulent FCV strain with a broad serum cross-neutralization profile and protection against challenge of a highly virulent vs feline calicivirus.
Rong S; Lowery D; Floyd-Hawkins K; King V
Virus Res; 2014 Aug; 188():60-7. PubMed ID: 24685673
[TBL] [Abstract][Full Text] [Related]
4. A dual-strain feline calicivirus vaccine stimulates broader cross-neutralization antibodies than a single-strain vaccine and lessens clinical signs in vaccinated cats when challenged with a homologous feline calicivirus strain associated with virulent systemic disease.
Huang C; Hess J; Gill M; Hustead D
J Feline Med Surg; 2010 Feb; 12(2):129-37. PubMed ID: 19836282
[TBL] [Abstract][Full Text] [Related]
5. Comparative efficacy of the Leucofeligen™ FeLV/RCP and Purevax™ RCP FeLV vaccines against infection with circulating feline Calicivirus.
Almeras T; Schreiber P; Fournel S; Martin V; Nicolas CS; Fontaine C; Lesbros C; Gueguen S
BMC Vet Res; 2017 Oct; 13(1):300. PubMed ID: 29017551
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms for persistence of acute and chronic feline calicivirus infections in the face of vaccination.
Pedersen NC; Hawkins KF
Vet Microbiol; 1995 Nov; 47(1-2):141-56. PubMed ID: 8604546
[TBL] [Abstract][Full Text] [Related]
7. Three-year duration of immunity for feline herpesvirus and calicivirus evaluated in a controlled vaccination-challenge laboratory trial.
Jas D; Frances-Duvert V; Vernes D; Guigal PM; Poulet H
Vet Microbiol; 2015 May; 177(1-2):123-31. PubMed ID: 25824128
[TBL] [Abstract][Full Text] [Related]
8. Immunisation with a combination of two complementary feline calicivirus strains induces a broad cross-protection against heterologous challenges.
Poulet H; Brunet S; Leroy V; Chappuis G
Vet Microbiol; 2005 Mar; 106(1-2):17-31. PubMed ID: 15737470
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the ability of feline calicivirus (FCV) vaccines to neutralise a panel of current UK FCV isolates.
Porter CJ; Radford AD; Gaskell RM; Ryvar R; Coyne KP; Pinchbeck GL; Dawson S
J Feline Med Surg; 2008 Feb; 10(1):32-40. PubMed ID: 17720588
[TBL] [Abstract][Full Text] [Related]
10. Genogrouping of vaccine breakdown strains (VBS) of feline calicivirus in Japan.
Ohe K; Sakai S; Takahasi T; Sunaga F; Murakami M; Kiuchi A; Fukuyama M; Furuhata K; Hara M; Ishikawa Y; Taneno A
Vet Res Commun; 2007 May; 31(4):497-507. PubMed ID: 17225086
[TBL] [Abstract][Full Text] [Related]
11. Three-year duration of immunity in cats following vaccination against feline rhinotracheitis virus, feline calicivirus, and feline panleukopenia virus.
Gore TC; Lakshmanan N; Williams JR; Jirjis FF; Chester ST; Duncan KL; Coyne MJ; Lum MA; Sterner FJ
Vet Ther; 2006; 7(3):213-22. PubMed ID: 17039444
[TBL] [Abstract][Full Text] [Related]
12. Onset of immunity in kittens after vaccination with a non-adjuvanted vaccine against feline panleucopenia, feline calicivirus and feline herpesvirus.
Jas D; Aeberlé C; Lacombe V; Guiot AL; Poulet H
Vet J; 2009 Oct; 182(1):86-93. PubMed ID: 18694649
[TBL] [Abstract][Full Text] [Related]
13. Intranasal immunization with inactivated feline calicivirus particles confers robust protection against homologous virus and suppression against heterologous virus in cats.
Sato H; Sehata G; Okada N; Iwamoto K; Masubuchi K; Kainuma R; Noda T; Igarashi T; Sawada T; Noro T; Oishi E
J Gen Virol; 2017 Jul; 98(7):1730-1738. PubMed ID: 28691897
[TBL] [Abstract][Full Text] [Related]
14. Application of chimeric feline foamy virus-based retroviral vectors for the induction of antiviral immunity in cats.
Schwantes A; Truyen U; Weikel J; Weiss C; Löchelt M
J Virol; 2003 Jul; 77(14):7830-42. PubMed ID: 12829823
[TBL] [Abstract][Full Text] [Related]
15. Temporally separated feline calicivirus isolates do not cluster phylogenetically and are similarly neutralised by high-titre vaccine strain FCV-F9 antisera in vitro.
Smith SL; Afonso MM; Pinchbeck GL; Gaskell RM; Dawson S; Radford AD
J Feline Med Surg; 2020 Jun; 22(6):602-607. PubMed ID: 31411533
[TBL] [Abstract][Full Text] [Related]
16. Long-term immunity in cats vaccinated with an inactivated trivalent vaccine.
Scott FW; Geissinger CM
Am J Vet Res; 1999 May; 60(5):652-8. PubMed ID: 10328440
[TBL] [Abstract][Full Text] [Related]
17. Use of serologic tests to predict resistance to feline herpesvirus 1, feline calicivirus, and feline parvovirus infection in cats.
Lappin MR; Andrews J; Simpson D; Jensen WA
J Am Vet Med Assoc; 2002 Jan; 220(1):38-42. PubMed ID: 12680445
[TBL] [Abstract][Full Text] [Related]
18. Feline calicivirus infection. ABCD guidelines on prevention and management.
Radford AD; Addie D; Belák S; Boucraut-Baralon C; Egberink H; Frymus T; Gruffydd-Jones T; Hartmann K; Hosie MJ; Lloret A; Lutz H; Marsilio F; Pennisi MG; Thiry E; Truyen U; Horzinek MC
J Feline Med Surg; 2009 Jul; 11(7):556-64. PubMed ID: 19481035
[TBL] [Abstract][Full Text] [Related]
19. Feline panleukopenia virus, feline herpesvirus-1 and feline calicivirus antibody responses in seronegative specific pathogen-free kittens after parenteral administration of an inactivated FVRCP vaccine or a modified live FVRCP vaccine.
Lappin MR
J Feline Med Surg; 2012 Feb; 14(2):161-4. PubMed ID: 22314095
[TBL] [Abstract][Full Text] [Related]
20. A multi-national European cross-sectional study of feline calicivirus epidemiology, diversity and vaccine cross-reactivity.
Afonso MM; Pinchbeck GL; Smith SL; Daly JM; Gaskell RM; Dawson S; Radford AD
Vaccine; 2017 May; 35(20):2753-2760. PubMed ID: 28389099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
